Zhu, Z., & Chai, Y. (2021). First-Line EGFR-TKIs Treatment in Stage I Non-Small-Cell Lung Cancer Patients Harboring EGFR Gene Mutations with Postoperative Intrapulmonary Recurrence. Cancer Manag Res.
Styl ChicagoZhu, Zhouyu, a Ying Chai. "First-Line EGFR-TKIs Treatment in Stage I Non-Small-Cell Lung Cancer Patients Harboring EGFR Gene Mutations With Postoperative Intrapulmonary Recurrence." Cancer Manag Res 2021.
Citace podle MLAZhu, Zhouyu, a Ying Chai. "First-Line EGFR-TKIs Treatment in Stage I Non-Small-Cell Lung Cancer Patients Harboring EGFR Gene Mutations With Postoperative Intrapulmonary Recurrence." Cancer Manag Res 2021.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..